Results: 935 news stories
For the past decade, adolescent mental health disorders have skyrocketed, an issue propelled even further by the COVID-19 pandemic. Mental health has declined surreptitiously for millions of people in recent years, affecting even the youngest among us. According to the American Academy of Child Psychiatry (AACAP), each year about one in six children aged 6-17 […]
A first-of-its-kind investigation into the mechanisms behind diabetes and obesity in people with spinal cord injury and the antidiabetic and anti-obesity effects of semaglutide was recently approved for $3 million in National Institutes of Health funding. “This is one population in which they are susceptible to be more obese and having worse diabetes risk and […]
¸£ÀûÒ»ÇøÔÚÏß urologist demonstrates potential of valproic acid-DHA in lessening risk of contracting COVID-19 When the world locked down due to the COVID-19 pandemic in 2020, rather than slowing down, this distinguished urologist and medical educator merely switched gears. Ronald Rodriguez, MD, PhD, is a professor of medical education and urology at Joe […]
Okeanis Vaou, MD, associate professor and chief of the Movement Disorders Division in the Department of Neurology, was interviewed for this news segement. Watch Now
Austin Lemke, PsyD, clinical psychologist at ¸£ÀûÒ»ÇøÔÚÏß’s New Opportunities for Wellness (NOW) Adult Behavioral Health Clinic, and Megan Fredrick, MA, LPC-S, NOW Clinic director of programs, both with the Department of Psychiatry and Behavioral Sciences, are quoted in this article. Read More
Andrew J. Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, was quoted in this article. Read More
Curtis Bone, MD, MHS, departments of Psychiatry and Behavioral Sciences and Family and Community Medicine, and board-certified addiction medicine physician at the Be Well Institute on Substance Use and Related Disorders, was interviewed for this article. Watch Now
Curtis Bone, MD, MHS, departments of Psychiatry and Behavioral Sciences and Family and Community Medicine, and board-certified addiction medicine physician at the Be Well Institute on Substance Use and Related Disorders, was interviewed for this article. Read More
¸£ÀûÒ»ÇøÔÚÏß has recommitted itself for the fourth year as the exclusive official health care partner of The University of Texas at San Antonio athletics programs, including football, basketball, baseball, volleyball and soccer programs. As part of the partnership, the two-time conference champion ¸£ÀûÒ»ÇøÔÚÏß football team will take the home field on […]
As part of the $52 million Cancer Prevention and Research Institute of Texas (CPRIT) grant funding round announced in May, The University of Texas Health Science Center at San Antonio (¸£ÀûÒ»ÇøÔÚÏß) received a $2 million CPRIT recruitment (CPRIT Scholar) funding award to bring top cancer researcher, Maria Falzone, PhD, to the […]
Every molecule in cellular metabolism has a role to play. A breakdown in any part of this delicate balance can cause a chain reaction of negative health conditions. Acetyl-CoA is a necessary molecule in the bioenergetic process because it converts fuel sources into energy for the cells. For mammals, this fuel is usually glucose, which […]
Lack of oxygen can sensitize nerve cells, leading to long-term pain More than 100 million people worldwide are affected by obstructive sleep apnea. This health condition causes a person to stop breathing numerous times while they are sleeping. Reduced sleep time and sleep quality can lead to numerous health problems including obesity, high blood pressure, […]
Study will evaluate biomarkers and novel treatments for alcohol use disorder Brett Ginsburg, PhD, director of the Biochemical Pharmacology Analytical Laboratory at The University of Texas Health Science Center at San Antonio (¸£ÀûÒ»ÇøÔÚÏß), was selected as a performer with the Wellcome Leap Untangling Addiction program. Wellcome Leap is a U.S.-based nonprofit organization […]
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Physical Medicine and Rehabilitation, and director of its long COVID clinics, was featured in this story. Read More
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More